国療化研の英語

そのため、「新たな治験活性化５カ年計画」に基づき、中核病院・拠点医療機関 40か所程度に治験・臨床研究の人材を集中的に投入し、技能の集約化とスタッフの育成を図るとともに、効率的かつ迅速に国際共同治験・臨床研究が実施できる連携体制を構築する。具体的には、中核病院として 10 か所の医療機関、拠点医療機関として 30か所の医療機関に対し、それぞれ整備のための助成を行う。（2007 年度～）例文帳に追加

To this end, in accordance with the 'New Five-Year Clinical Trial Promotion Plan', clinical trial/research human resources shall be intensively channelled into around 40 core hospitals and medical bases in order to centralize skills and train staff, and at the same time a liaison framework shall be established to facilitate efficient and speedy multinational clinical trials and clinical researches. Specifically, assistance shall be given for the respective provision of 10 medical institutions as core hospitals and 30 as medical bases. (Fiscal 2007 ~ ) - 厚生労働省

他方、日本企業においては、国内の薬価引下げや医療費抑制策による経営環境の悪化、バイオ医薬品等の研究開発費の巨大化等を背景に、今までの経営手法では成長が望めなくなり、かつ外資の力に圧倒され、守勢に回らざるを得ない状況になった。例文帳に追加

Meanwhile, Japanese companies were faced with a situation in which they had little chance of achieving growth through current management methods,with a deteriorating business environment caused by drug price falls and medical fee restriction measures as well as escalating R&D fees for bio medicine. Overwhelmed by the power of foreign affiliates, Japanese companies had no choice but to take a defensive position. - 経済産業省

治験・臨床研究の活性化の必要性及び方向性について、以下の内容について共通認識を持ち、今後、特に我が国発の革新的な医薬品・医療機器をタイムリーかつシームレスに創出するために必要な治験・臨床研究の基盤の迅速な整備を強化していくことが確認された。例文帳に追加

In terms of the necessity and direction of clinical trial/study activation, it was affirmed that there be a common awareness regarding the content below, and that quick infrastructure development for clinical trials and studies that are required for the timely and seamless creation of innovative pharmaceuticals and medical devices by Japan in particular be reinforced. - 厚生労働省

中小企業のものづくり技術を活かして、医療現場の課題・ニーズに応える医療機器の開発・改良を促進するため、本事業では、厚生労働省及び文部科学省と連携し、①医療現場からのニーズが高く、課題解決に資する研究課題の選定② 地域の特色あるものづくり技術（切削、精密加工、コーティング等）を有する中小企業等と、それらの課題を有する医療機関や研究機関等とが連携した「医工連携」による医療機器の開発・改良　③臨床評価、実用化までの一貫した取組を行うことで、中小企業のものづくり技術を活かした医療機器の実用化を加速することにより、我が国における医療の質の向上と、ものづくり産業の新たな事業分野の開拓を実現する。（継続）（p.208 参照）例文帳に追加

This program will be implemented jointly by the Ministry of Health, Labour and Welfare and the Ministry of Education, Culture, Sports, Science and Technology in order to promote the development and modification of medical devices to meet needs and challenges in clinical medicine by using SMEs manufacturing technologies.　More specifically, the quality of medical care in Japan will be raised and new fields of manufacturing business will be developed by accelerating the commercialization of medical devices employing SMEs’ manufacturing technologies. This will be achieved by means of the following:　1) Selection of research problems contributing to much-needed resolution of challenges in clinical medicine　2) Development and modification of medical devices by “medical-industrial partnerships” involving collaboration between SMEs possessing locally distinctive manufacturing technologies (cutting, precision machining, and coating technologies, etc.) with medical and research institutions facing challenges that could be solved using those technologies.　3) End-to-end initiatives extending from clinical evaluation to commercialization (Continuation) (See p. 204.)発音を聞く  - 経済産業省

同時に、医薬品・医療機器の自立的な開発が我が国における恒常的な安全の確立につながること、また５カ年計画の目的にもあるとおり、医薬品・医療機器の治験を含む臨床研究の国内実施体制の確保及び強化は、我が国の当該産業の国際競争力の基礎となる日本発のイノベーションの創出やこれにより得られたエビデンスの世界への発信に必須であることを再認識するべきである。例文帳に追加

At the same time, it should be reaffirmed that autonomous development of pharmaceuticals and medical devices will lead to the establishment of constant safety in Japan. In addition, it should also be reaffirmed that the establishment and reinforcement of a domestic implementation system for clinical research that include clinical trials for pharmaceuticals and medical devices, as set as the goal of the 5Yearly Plan, are essential for the creation of Japanese innovation, which will be the foundation of international competitiveness of the relevant Japanese industries, as well as for the transmission of the obtained evidence to the world. - 厚生労働省

５カ年計画による治験・臨床研究の活性化の目指す方向性が、我が国から革新的医薬品・医療機器を創出すること及び世界における最新かつ質の高い医療のエビデンスの発信であることを全ての関係者が再認識し、各々に求められた重点的取組事項のうち残される課題に対して着実に取り組むべきである。例文帳に追加

All relevant parties should reaffirm that the activation of clinical trials and clinical research by means of the 5-Year Plan is aimed at creating innovative pharmaceuticals and medical devices in Japan and transmitting evidence of the latest and high-quality medical treatment to the world, and should work on steadily resolving the issues that remain among the priorities required of each person. - 厚生労働省

中間見直しにおいては、５カ年計画の策定後、急激に国際共同治験の実施数が増加している等の治験・臨床研究の環境の変化に鑑み、これまでに中核病院・拠点医療機関等を中心として治験・臨床研究の基盤整備に取り組んできた事項を評価するとともに、次の点を検討事項とした。例文帳に追加

In the mid-term review, the items that were being worked upon up to now for the infrastructure development of clinical trials and studies centered on core hospitals and central medical institutions, etc., were evaluated in view of the changes in the clinical trial/study environment, such as the rapid increase in the number of multinational clinical trials after the establishment of the 5 Yearly Plan, and the following items were set as the points for consideration: - 厚生労働省

「全国治験活性化３カ年計画」等により、大規模治験ネットワーク等が形成されてきたが、それだけでは治験・臨床研究の活性化には十分つながっていない現状が明らかとなり、これまでに構築された治験ネットワークの形成や支援に加えて、専門とする領域や医療機関連携の特色を有する等の治験・臨床研究の中核病院や拠点医療機関の整備が必要とされた。例文帳に追加

Although the clinical trial network has been formed under the 'Three-Year Nationwide Clinical Trial Promotion Plan' and other plans, it is clear that this alone has failed to promote clinical trials and clinical researches fully. The formation and support of the clinical trial network built up to date should be supplemented with core clinical trial/research hospitals and medical bases having specialist areas, medical center tie-ups or similar characteristics. - 厚生労働省